Nature Reviews Drug Discovery 9, 867–883 (2010)
In figure 7, the second column in panels a and b should have been labelled 'NDA/BLA applicant'. In the legend for figure 7, and in the article text related to this figure on p879, the subset of the drugs analysed in panel a are those with peak year sales above US$500 million, rather than mean peak year sales.
The online version of the original article can be found at 10.1038/nrd3251
About this article
Cite this article
Kneller, R. Erratum: The importance of new companies for drug discovery: origins of a decade of new drugs. Nat Rev Drug Discov 9, 955 (2010). https://doi.org/10.1038/nrd3326